Table 2.
Methods used to create bioactive glass scaffolds, and characteristics of the fabricated scaffolds.
| Method | Glass | Porosity (%) | Pore size (µm) | Strength* (MPa) | Reference |
|---|---|---|---|---|---|
| Thermal bonding of | |||||
| Particles | 13–93 | 40–45 | 100–300 | 22 ± 1 | [99] |
| Short fibers | 13–93 | 45–50 | >100 | 5 | [127] |
| Polymer foam replication | 45S5 | 89–92 | 510–720 | 0.4 ± 0.1 | [63] |
| 13–93 | 75–85 | 100–500 | 11 ± 1 | [102] | |
| 13–93B3 | 80–85 | 100–500 | 5 ± 0.5 | [66] | |
| Sol–gel foam | 70S30C | 82 | 500 (100)* | 2.4 | [123] |
| Unidirectional freezing of suspensions | 13–93 | 53–57 | 90–110 | 25 ± 3 | [110] |
| 13–93 | 50–55 | 60–120 | 27 ± 8 | [111] | |
| 13–93 | 50 | 50–150 | 47 ± 5 | [164] | |
| Solid freeform fabrication | |||||
| Selective laser sintering | 13–93 | 58–60 | 700–1000 | 15 ± 1 | [120] |
| Freeze extrusion fabrication | 13–93 | 50 | 300 | 140 ± 70 | [119] |
| Robocasting | 6P53B | 60 | 500 | 136 ± 22 | [118] |
Macropore diameter = 500 µm; interconnected pore diameter = 100 µm.